Welcome to Mexico’s Pavilion
and production, Mexico is your best option.
Get to Know
CONFIRMED PAVILION MEMBERS
CARNOT
AROCHI & LINDNER
GTO LIFE INNOVATION & TECHNOLOGIES CLUSTER
SILANES
INSTITUTO DE TERAPIA CELULAR
PISA
PARQUE PHARMA
HELIX
FIFARMA
EPIC PRO
CECYPE
AMEXCID
Through AMEXCID, Mexico offers and receives development cooperation. On the one hand, we share successful experiences, strengthen capacities, and exchange human, technical, and financial resources with developing countries, particularly in Central America and the Caribbean. On the other hand, we work with strategic partners to enhance our capabilities, improve our institutions, and generate tangible results that strengthen Mexico.
ccastillop@sre.gob.mx
Rafael Valencia, Director de Sistemas de Información,
rvalenciav@sre.gob.mx
AVANT-SANTÉ / ETCURAE
Offering a comprehensive spectrum of services, Avant Santé specializes in everything from Early Phase I first-in-human studies to regulatory services.
Our Phase I facility in Monterrey features 80 beds dedicated to healthy human BA/BE studies and 16 beds for early Phase 1 first-in-human studies. This state-of-the-art facility is particularly expert at conducting patient PD studies in asthma patients (methacholine challenge), early Phase 1 first-in-human studies, and healthy human BA/BE studies, adhering to the standards of USFDA, EMA, ANVISA, COFEPRIS, LATAM, and TGA.
Avant Santé also provides LATAM regulatory services through its subsidiary, Udela Global, offering a range of services including product dossier preparation, attendance at new molecule committee meetings, facilitation of technical meetings with regulatory agencies, and acting as sponsors’ representatives during interactions with regulatory bodies
Avant Santé plays a significant role in late-phase clinical trials (Phase II to IV) focusing on metabolic and liver disorders such as obesity, T2DM, dyslipidemia, MAFLD/MASH, cirrhosis, alcohol hepatitis, PBC, PCOS, HCC, and autoimmune hepatitis. With a site network spanning five LATAM countries and encompassing over 100 sites, we are positioned to make substantial progress in the field of clinical research. Avant Santé also has collaboration with public institutions in Mexico through its Subsidiary EtCurae® for an exclusive access of patient population.
Murali Pandela, Chief Scientific Officer and Business Development
INCIDE
afarias@incide.mx
CECYPE
We offer a range of other complimentary services for clinical trials that include: Biologic/Biosimilar trials, Vaccine trials, Tailored analytical assays for PK and ADAs, Pharmacodynamics, Hospital alliances for trials with patients, Bridging studies, Ethics and research committees, Preclinical trials and more.
CECYPE, is not just a CRO; It’s a dedicated partner with a long-standing record of success. We have the expertise, the facilities, and the passion to ensure your biologic/biosimilar trials are conducted with the utmost care, precision and strict adherence to good clinical practices.
José Herrera, COO
jose.herrera@cecype.com
Phone: +52 (443) 323 2828
EPIC-CRO
At EPIC, we help develop and bring new molecules and developments to the regulatory process through trial design, management, site selections, CRFs, ICF, and other material developments emphasizing collaborative work with your team and our clinical and regulatory experts to ensure cost-effective results.
Phone: +52 (55) 56.89.43.90 ext.102
rp@epic-cro.com;
GRUPOT ITRASIG
Gabriel García: vinculacion@t4oligo.com
Phone: +52 477 520 0906
IPN
By 2036, we envision ourselves as a high-quality technological education institution, characterized by a focus on sustainability, a strong sense of identity, and international recognition. We strive to be among the top universities in the world, achieved through international collaboration with leading schools and research centers. Our leadership will be defined by our contributions to science and technology, making a meaningful impact while upholding a sense of social responsibility. We value diversity and gender equity, fostering an inclusive environment for all.
LIOMONT
The company is looking to out-license our biosimilar products and is also looking for partners with assets that can strengthen its portfolio. Additionally, they seek to establish partnerships with biotech or vaccine companies that might be interested in manufacturing their products in their state-of-the-art facility where they have a capacity for both cell culture and aseptic filling of vials.
Alejandra Cruz, Gerente de Innovación: mcruz@liomont.com.mx
Phone: +52 (55) 55 – 6166 – 2537
NEW GENESIS
Moureen Valdés: mvaldes@newgenesis.cl
PISA FARMACÉUTICA
For more than seven decades, growth at PiSA® Farmacéutica has been a constant thanks to its human capital. We are committed to excellence, aware that each of our actions and activities are to fulfill our reason for being: “A Life at the Service of Life.”
At PiSA® Farmacéutica we distinguish ourselves for our production capacity and extensive experience in the Mexican and Latin American market; this has allowed us to set the tone for our growth and international expansion.
vinculacioncorporativa.gp@gmail.com
PRAGMATEC
• HealthTech Landscape Reports in the region.
• Scouting of new technologies for your open innovation strategies (researchers or startups).
• Matchmaking with potential partners such as universities, research centers, clinical trials offices, manufacturing companies, or specialized chambers of commerce.
• Connections with regulatory experts to introduce new products in this market.
• Exploratory interviews with potential customers (B2B/B2C).
• First connections with federal and local governments for nearshoring strategies in Mexico.
GUADALAJARA, JALISCO, MEXICO.
REDOTT
The purpose of its creation was to strengthen the innovation ecosystem, share efforts, and collaborate in actions of common interest for the development and consolidation of the technology transfer and commercialization function, making visible the technological offer of Higher Research Institutions (IES). They seek to complement experiences in training and mobility, success stories, monitoring of activity measurement indicators, and possibilities for developing technologies among HEIs to optimize economies of scale and create a culture regarding intellectual property.
Mtro. Guillermo Roura
Phone: +52 1 55 2095 1761
PRAGMATEC
We can offer you strategic relationships in these specific goals:
– HealthTech Landscape Reports in the region.
– Scoutting of new technologies for your Open innovation strategies (researchers or startups).
– Matchmaking with potential partners such as universities, research centers, clinical trials offices, manufacturing companies, or specialized chambers of commerce.
– Connections with regulatory experts to introduce new products in this market.
– Exploratory interviews with potential customers (B2B/B2C).
– Firsts connections with federal and local governments for nearshoring strategies in Mexico.
CIATEJ CIATEJ
Contact: Evaristo Urzua eurzua@ciatej.mx
Website: https://ciatej.mx/
UDG
Website: https://www.udg.mx/
Contact: Ramon Willman ramon.willman@udg.mx; ramon.willman@udg.mx
Email:vsanchez@pragmatec.com.mx
TIJUANA EDC
- Expert Guidance: Meet our team of professionals who have an in-depth understanding of Baja California’s economic landscape. Receive expert guidance and insights to make well-informed decisions.
- Comprehensive Information: Access a wealth of information, including market trends, industry-specific data, and regulatory requirements. Equip yourself with the knowledge needed to shape your business strategy effectively.
- Site Selection Resources: Finding the ideal location for your manufacturing operations is paramount. Discover how we can help you identify and evaluate suitable sites tailored to your specific needs.
- Connection Building: Establishing key connections within the local business ecosystem is vital. Engage in networking sessions to meet local suppliers, partners, and government entities, ensuring a smooth entry into Baja California’s business community
TIJUANA, BAJA CALIFORNIA, MEXICO
UDELÁ
Udelá Global offers a comprehensive service package, or clients can choose specific services needed:
• Regulatory consulting and strategy development for market entry in LATAM.
• Legal representation to navigate legalities and ensure compliance.
• Warehousing and distribution solutions tailored for healthcare products.
Brenda Zamora Martínez: bzamora@udelaglobal.com,
Daniel Eguiluz: deguiluz@udelaglobal.com
Phone: +52 (55) 86 – 2687 – 90 Ext.1006
Tijuana EDC
Email: lorelei@tijuanaedc.org
UDIBI
Sergio Torres Pérez: sergio.torres@udibi.com.mx
Juan C. Almagro: juan.almagro@udibi.com.mx
ORGANON
Our manufacturing facility, located south of Mexico City, provides capabilities in Oral Solid Dosage manufacturing and Primary/Secondary packaging, allowing great flexibility in logistics, whether by land, sea, or air. We supply more than 30 countries, including North and Latin America and others around the world. The facility has the installed capacity to produce more than 50 million packs annually and satisfy the demand of potential partners.
Our Plant stands as a testament to our commitment to excellence, innovation and continuing improvement for our customers. Our state-of-the-art equipment and highly skilled professionals ensure every product meets and exceeds industry benchmarks.
Berenice Aranda
Jean Pierre Lostaunau